Demans için Risk Faktörü: Obezite

Obezite ve demans gittikçe prevalansı artan ciddi sağlık sorunlarıdır. Son yıllarda obezite ve demans arasındaki ilişkiyi inceleyen çalışmalar artmıştır. Obezitenin diyabet, kardiyovasküler hastalıklar, kanser gibi kronik hastalıkların oluşumunda etkisi olduğu bilinmekle beraber, literatürde demans üzerine etkisini inceleyen çalışmaların sonuçları çelişkilidir. Çalışmalar, en sık görülen Alzheimer tipi demans üzerine yoğunlaşmıştır. Obezite ve demans arasındaki mekanizma birçok yönden değerlendirilmiş olsa da kesin bir sonuca varılamamıştır. Bu ilişkinin değerlendirilmesinde uzunlamasına yapılacak olan takipli çalışmalara ihtiyaç olduğu düşünülmektedir

The Risk Factor for Dementia: Obesity

Obesity and dementia, which prevelance of them are increasing day by day, are serious health problems. In recent years, the studies which are examining the relationship between obesity and dementia has increased. It is known that obesity effects on chronic diseases such as diabetes mellitus, cardiovascular disease, cancer, however, the results of studies examining the effect on dementia are inconsistent in the literature. Studies focused on dementia which is the most common Alzheimer's type. Although the mechanism between obesity and dementia evaluated in many ways, a definite conclusion hasn't been reached. It is considered that it is needed to carry out follow-up and longitudinal studies for the evalution of this relationship

PDF

___

http://www.who.int/topics/obesity/en/ (erişim tarihi: 09.09.2015). 2.
http://www.who.int/mediacentre/factsheets/fs311/en/ (erişim tarihi: 08.09.2015). 3.
Reilly JJ, Methven E, McDowell ZC, Hacking B, Alexander D, Stewart L
et al. Health consequences of obesity. Arch Dis Child 2003;88:748-52. 4.
Arnoldussen IAC, Kiliaan AJ, Gustafson DR. Obesity and dementia:
Adipokines interact with the brain. Eur Neuropsychopharmaco 2014;24:1982-99. 5.
Hanağası HA. Demans kavramı ve hastaya yaklaşım. Klinik Gelişim 2010;23;1:44-7. 6.
Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W , Ferri CP. The global
prevalence of dementia: A systematic review and metaanalysis.
Alzheimers Dement 2013 ;9:63-75. 7.
Edelberg HK, Wei JY. The biology of Alzheimer's disease. Mech Ageing Dev 1996;91:95-114. 8.
Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al.
Global prevalence of dementia: A Delphi consensus study. Lancet 2005;17;366:2112-7. 9.
http://www.alz.org/alzheimers_disease_what_is_alzheimers.asp. (erişim tarihi: 20.09.2015) .
http://www.alz.org/alzheimers_disease_causes_risk_factors.asp (erişim tarihi: 20.09.2015).
Roccisano D, Henneberg M, Saniotis A. A possible cause of Alzheimer's dementia - Industrial soy foods. Med Hypotheses 2014;82:250-4.
Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med ;163:1524-8.
Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O'Meara ES, Longstreth WT, et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 2009;66: 336-42.
Atti AR, Palmer K, Volpato S, Winblad B, Ronchi DD, Fratiglioni L. Late life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project. J Am Geriatr Soc 2008;56: 111-6.
15. Luchsinger JA, Patel B, Tang MX, Schupf N, Mayeux R. Measures of adiposity and dementia risk in elderly persons. Arch Neurol 2007;64: 392-8.
16.Anstey KJ, Cherbuin N, Budge M, Young J. Body mass index in midlife and latelife as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev 2011;12:e426-e37.
Xu WL, Atti AR, Gatz M, Pedersen NL, Johansson B, Fratiglioni L. Midlife overweight and obesity increase late-life dementia risk: a population based twin study. Neurology 2011;76:1568-74.
Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP,Yaffe K. Central obesity and increased risk of dementia more than three decades later. Neurology 2008;71:1057-64.
Gustafson DR, Backman K, Waern M, Ostling S, Guo X, Zandi P, et al. Adiposity indicators and dementia over 32 years in Sweden. Neurology ;73:1559-66.
Beydoun MA, Beydoun HA, Wang Y. Obesity and central obesity as risk factors for incident dementia and it's subtypes: a systematic review and meta-analysis. Obes Rev 2008; 9: 204-18.
Gorospe EC, Dave JK. The risk of dementia with increased body mass index. Age Aging 2007; 36: 23-29.
Loef M, Walach H. Midlife obesity and dementia:meta-analysis and adjusted forecast of dementia prevalence in the United States and China. Obesity 2013;21:E51-E55.
Harvey J, Shanley LJ, O'Malley D, Irving AJ. Leptin: a potential cognitive enhancer? Biochem Soc Trans 2005;33:1029-32.
Razay G, Vreugdenhil A, Wilcock G. Obesity, abdominal obesity and alzheimer disease. Dement Geriatr Cogn Disord 2006;22:173-76.
25.Zhou Y, Flaherty JH,Huang CQ, Lu ZC,Dong BR.Association between body mass ındex and cognitive function among Chinese Nonagenarians/Centenarians. Dement Geriatr Cogn Disord 2010;30:517-24.
26.Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L .Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care 2000;23: 465-71. 27. Power BD, Alfonso H, Flicker L, Hankey GJ, Yeap BB, Almeida OP. Body adiposity in later life and the ıncidence of dementia: the health in men study. Plos One 2011;6:e17902.
28. Kurth F, Levitt JG, Philips OR, Luders E, Woods RP, Mazziotta JC et al. Relationships between gray matter, body mass ındex, and waist circumference in healthy adults. Hum Brain Mapp 2013; 34:1737-46.
29. Hughes TF, Borenstein AR, Schofield E, Wu Y, Larson EB. Association between late-life body mass index and dementia: The Kame Project. Neurology2009;72:1741-46
30. Solfrizzi V, Scafato E, Capurso C, D'Introno A, Colacicco AM, Frisardi V, et al. Metabolic syndrome and the risk of vascular dementia: the Italian longitudinal study on ageing. J Neurol Neurosurg Psychiatry 2010; 81: 433-40.
31. Bagger YZ, Tanko LB, Alexandersen P, Qin G, Christiansen C. The implications of body fat mass and fat distribution for cognitive function in elderly women. Obes Res 2004;12: 1519-26.
32. Hudetz JA, Gandhi SD, Iqbal Z, Patterso KM, Pagel PS.Elevated postoperative inflammatory biomarkers are associated with short- and medium-term cognitive dysfunction after coronary artery surgery. J Anesth 2011, 25:1-9.
33. El-Atat F, Aneja A, McFarlane S, Sowers J. Obesity and hypertension. Endocrinol Metab Clin North Am 2003; 32: 823-54.
34. Swan GE, Carmelli D, Larue A. Systolic blood pressure tracking over 25- years and cognitive performance in older adults. Stroke 1998; 29: 2334-40.
35. Glynn RJ, Beckett LA, Hebert LE, Morris MC, Scherr PA, Evans DA. Current and remote blood pressure and cognitive decline. JAMA 1999; 281: 438-45.
36. Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett- Connor E, Krueger K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 2004; 63: 658-63.
37. Strachan MW, Reynolds RM, Marioni RE, Price JF: Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol 2011;7:108-114.
38. Albanese E, Taylor C, Siervo M, Stewart R, Prince MJ, Acosta D. Dementia severity and weight loss: A comparison across eight cohorts. The 10/66 study. Alzheimers Dement 2013;9: 649-56.
39. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country years and 2.7 million participants. Lancet 2011;378:31-40.
40. Lakhan SE, Kirchgessner A. The emerging role of dietary fructose in obesity and cognitive decline. Nutr J 2013;12:114.
41. Ross AP, Bartness TJ, Mielke JG, Parent MB.A high fructose diet impairs spatial memory in male rats. Neurobiol Learn Mem 2009;92:410-6.
42. Davidson TL, Kanoski SE, Walls EK, Jarrard LE. Memory inhibition and energy regulation. Physiol Behav 2005;86: 731-46.
43. Power DA, Noel J, Collins R, O'Neill D. Circulating leptin levels and weight loss in Alzheimer's disease patients. Dement Geriatr Cogn Disord 2001;12:167-70.
44. Williams JW, Plassman BL, Burke JR, Holsinger T, Benjamin S. Preventing Alzheimer's disease and cognitive decline. Evidence Report/Technical Assessment No. 193. National Institutes of Health: Durham 2010. Rapor No: 10-E005.
45. Nelson C, Wengreen HJ, Munger RG, Corcoran CD. Dietary folate, vitamin B-12, vitamin B-6 and incident Alzheimer's disease: the cache county memory, health and aging study. J Nutr Health Aging 2009; 13: 899-905.
46. Fotuhi M, Mohassel P, Yaffe K. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol 2009; 5:140-52.
47. Middleton LE, Yaffe K. Promising strategies for the prevention of dementia. Arch Neurol 2009; 66: 1210-15.
48. Aller EE, Abete I, Astrup A, Martinez JA, Van Baak MA: Starches, sugars and obesity. Nutrients 2011;3:341-69.
49. Wang PN, Yang CL, Lin KN, Chen WT, Chwang LC, Liu HC. Weight loss, nutritional status and physical activity in patients with Alzheimer's disease. A controlled study. J Neurol 2004; 251: 314-20.
50. Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 2002; 59: 371-8.